CHRNA4 and Anxiety: These include increased subcortical nAChR nicotine binding, higher plasma levels of nicotine with repeated administration, more severe withdrawal symptoms (thought to be associated with ovarian hormones), greater HPA axis activity and corticosterone release, and enhanced stress/anxiety-like behavior in female rodents (Cross et al., 2017; Dome et al., 2010).